Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,632,000 | 2,166,000 | 416,000 | 1,298,000 | 1,780,000 |
| Marketable Securities | 42,153,000 | 17,806,000 | 22,316,000 | 34,825,000 | 31,524,000 |
| Receivables | 10,231,000 | 12,305,000 | 10,952,000 | 16,076,000 | 15,155,000 |
| Inventories | 10,310,000 | 9,541,000 | 8,981,000 | 9,513,000 | 10,454,000 |
| Income taxes - deferred | N/A | N/A | N/A | 2,544,000 | 2,583,000 |
| Other current assets | 8,021,000 | 8,260,000 | 8,594,000 | 6,147,000 | 5,970,000 |
| TOTAL | $73,347,000 | $50,078,000 | $51,259,000 | $70,403,000 | $67,466,000 |
| Non-Current Assets | |||||
| PPE Net | 17,488,000 | 17,052,000 | 16,274,000 | 15,441,000 | 15,244,000 |
| Investments And Advances | 15,066,000 | 14,743,000 | 15,069,000 | 13,888,000 | 18,962,000 |
| Intangibles | 92,978,000 | 93,478,000 | 94,745,000 | 77,592,000 | 78,956,000 |
| Other Non-Current Assets | 21,289,000 | 20,267,000 | 19,856,000 | 18,026,000 | 14,661,000 |
| TOTAL | $146,821,000 | $145,540,000 | $145,944,000 | $124,947,000 | $127,823,000 |
| Total Assets | $220,168,000 | $195,617,000 | $197,205,000 | $195,350,000 | $195,290,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,985,000 | 4,188,000 | 2,945,000 | 4,040,000 | 5,990,000 |
| Accounts payable and accrued liabilities | 6,081,000 | 6,123,000 | 6,809,000 | 6,267,000 | 6,208,000 |
| Accrued Expenses | 1,972,000 | 2,277,000 | 3,407,000 | 2,852,000 | 1,997,000 |
| Other current liabilities | 16,079,000 | 20,255,000 | 22,568,000 | 19,647,000 | 23,816,000 |
| TOTAL | $34,647,000 | $36,562,000 | $42,138,000 | $44,314,000 | $47,410,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,356,000 | 31,704,000 | 32,884,000 | 32,629,000 | 34,294,000 |
| Deferred Revenues | 1,286,000 | 1,750,000 | 2,520,000 | 6,191,000 | 3,804,000 |
| aiOther Non-Current Liabilities | 23,628,000 | 25,035,000 | 25,234,000 | 24,885,000 | 25,552,000 |
| TOTAL | $86,227,000 | $57,819,000 | $59,149,000 | $58,145,000 | $60,410,000 |
| Total Liabilities | $120,875,000 | $94,381,000 | $101,288,000 | $102,459,000 | $107,821,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,645,960 | 5,645,307 | 5,619,075 | 5,613,315 | 5,612,352 |
| Common Shares | 478,000 | 478,000 | 476,000 | 476,000 | 476,000 |
| Retained earnings | 128,796,000 | 131,102,000 | 125,656,000 | 122,967,000 | 116,608,000 |
| Other shareholders' equity | -7,828,000 | -8,024,000 | -8,049,000 | -7,966,000 | -6,859,000 |
| TOTAL | $99,293,000 | $101,236,000 | $95,916,000 | $92,891,000 | $87,469,000 |
| Total Liabilities And Equity | $220,168,000 | $195,617,000 | $197,204,000 | $195,350,000 | $195,290,000 |